Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.50) per share. This is a 38.27 percent increase over losses of $(0.81) per share from the same period last year. The company reported $25.43 thousand in sales this quarter. This is a 173.35 percent increase over sales of $9.30 thousand the same period last year.